FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310949650> ?p ?o ?g. }

• W4310949650 endingPage "432" @default.
• W4310949650 startingPage "423" @default.
• W4310949650 abstract "<b><i>Introduction:</i></b> We investigated the associations between antecedent all-cause CVD diagnoses, cause-specific CVD diagnosis, and CVD medication prescriptions with the risk of developing amyotrophic lateral sclerosis (ALS). <b><i>Materials and Methods:</i></b> We conducted a population-based case-control study of U.S. Medicare enrollees from 2006 to 2013. The final sample included 3,714 incident ALS cases and 18,570 controls (matched on age, sex, enrollment length, and county). Information was collected from Medicare Parts A, B, and D administrative claims data on hypertension, ischemic heart disease, heart failure, acute myocardial infarction, atrial fibrillation, prescriptions of angiotensin-converting enzyme inhibitors, angiotensin II receptors blockers, calcium channel blockers, beta blockers, and antiarrhythmics. Associations were evaluated using conditional logistic regression adjusting for age, sex, race/ethnicity, geographical location, alcohol and tobacco use, and socioeconomic status. <b><i>Results:</i></b> The odds ratio (OR) for having one or more ICD-9 codes for any cardiovascular disease diagnosis at least 24 months prior to the date of ALS diagnosis was 0.85 (95% confidence interval [CI]: 0.78–0.92). Cardiovascular conditions that were inversely associated with ALS included heart failure (OR = 0.79; 95% CI 0.70–0.89), atrial fibrillation (OR = 0.81; 95% CI 0.77–0.92), and hypertension (OR = 0.91; 95% CI 0.84–0.98). Exposures to several classes of cardiovascular medications were inversely associated with ALS risk even after adjusting for confounding by indication, including ACE inhibitors (OR = 0.84, 95% CI 0.77–0.91), calcium channel blockers (OR = 0.64, 95% CI 0.59–0.70), and beta blockers (OR = 0.76, 95% CI 0.71–0.83). <b><i>Discussion/Conclusion:</i></b> These findings merit additional research, including animal studies and pilot clinical trials, to further evaluate and evidence the effects of ACEIs, CCBs, and BBs on the risk of developing and clinical expression of ALS." @default.
• W4310949650 created "2022-12-21" @default.
• W4310949650 creator A5046454356 @default.
• W4310949650 creator A5046463832 @default.
• W4310949650 creator A5057215950 @default.
• W4310949650 creator A5066514159 @default.
• W4310949650 creator A5073441790 @default.
• W4310949650 creator A5088764375 @default.
• W4310949650 date "2022-01-01" @default.
• W4310949650 modified "2023-10-14" @default.
• W4310949650 title "Cardiovascular Diseases, Medications, and ALS: A Population-Based Case-Control Study" @default.
• W4310949650 cites W150226877 @default.
• W4310949650 cites W1585186077 @default.
• W4310949650 cites W1680107906 @default.
• W4310949650 cites W1908609350 @default.
• W4310949650 cites W1916801516 @default.
• W4310949650 cites W1965809483 @default.
• W4310949650 cites W1978209044 @default.
• W4310949650 cites W1982564582 @default.
• W4310949650 cites W1985000677 @default.
• W4310949650 cites W1992040046 @default.
• W4310949650 cites W1996024251 @default.
• W4310949650 cites W1996204664 @default.
• W4310949650 cites W2001386533 @default.
• W4310949650 cites W2012235795 @default.
• W4310949650 cites W2033158384 @default.
• W4310949650 cites W2046794219 @default.
• W4310949650 cites W2058483361 @default.
• W4310949650 cites W2065515412 @default.
• W4310949650 cites W2070712250 @default.
• W4310949650 cites W2080581405 @default.
• W4310949650 cites W2085688898 @default.
• W4310949650 cites W2089323476 @default.
• W4310949650 cites W2126854592 @default.
• W4310949650 cites W2127966420 @default.
• W4310949650 cites W2136613147 @default.
• W4310949650 cites W2137867748 @default.
• W4310949650 cites W2144507462 @default.
• W4310949650 cites W2155221045 @default.
• W4310949650 cites W2274326662 @default.
• W4310949650 cites W2298338128 @default.
• W4310949650 cites W2335530968 @default.
• W4310949650 cites W2341035499 @default.
• W4310949650 cites W2400892929 @default.
• W4310949650 cites W2477934451 @default.
• W4310949650 cites W2511577826 @default.
• W4310949650 cites W2625713378 @default.
• W4310949650 cites W2791037961 @default.
• W4310949650 cites W2979624785 @default.
• W4310949650 cites W2983948195 @default.
• W4310949650 cites W3007476749 @default.
• W4310949650 cites W3047007063 @default.
• W4310949650 cites W3088774699 @default.
• W4310949650 cites W3091082500 @default.
• W4310949650 cites W3117515514 @default.
• W4310949650 cites W3164904402 @default.
• W4310949650 cites W31801189 @default.
• W4310949650 cites W4205423701 @default.
• W4310949650 cites W4239910162 @default.
• W4310949650 cites W4281551610 @default.
• W4310949650 doi "https://doi.org/10.1159/000526982" @default.
• W4310949650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36481735" @default.
• W4310949650 hasPublicationYear "2022" @default.
• W4310949650 type Work @default.
• W4310949650 citedByCount "0" @default.
• W4310949650 crossrefType "journal-article" @default.
• W4310949650 hasAuthorship W4310949650A5046454356 @default.
• W4310949650 hasAuthorship W4310949650A5046463832 @default.
• W4310949650 hasAuthorship W4310949650A5057215950 @default.
• W4310949650 hasAuthorship W4310949650A5066514159 @default.
• W4310949650 hasAuthorship W4310949650A5073441790 @default.
• W4310949650 hasAuthorship W4310949650A5088764375 @default.
• W4310949650 hasBestOaLocation W43109496501 @default.
• W4310949650 hasConcept C126322002 @default.
• W4310949650 hasConcept C156957248 @default.
• W4310949650 hasConcept C164705383 @default.
• W4310949650 hasConcept C2778198053 @default.
• W4310949650 hasConcept C2779161974 @default.
• W4310949650 hasConcept C2908647359 @default.
• W4310949650 hasConcept C500558357 @default.
• W4310949650 hasConcept C71924100 @default.
• W4310949650 hasConcept C99454951 @default.
• W4310949650 hasConceptScore W4310949650C126322002 @default.
• W4310949650 hasConceptScore W4310949650C156957248 @default.
• W4310949650 hasConceptScore W4310949650C164705383 @default.
• W4310949650 hasConceptScore W4310949650C2778198053 @default.
• W4310949650 hasConceptScore W4310949650C2779161974 @default.
• W4310949650 hasConceptScore W4310949650C2908647359 @default.
• W4310949650 hasConceptScore W4310949650C500558357 @default.
• W4310949650 hasConceptScore W4310949650C71924100 @default.
• W4310949650 hasConceptScore W4310949650C99454951 @default.
• W4310949650 hasIssue "6" @default.
• W4310949650 hasLocation W43109496501 @default.
• W4310949650 hasLocation W43109496502 @default.
• W4310949650 hasLocation W43109496503 @default.
• W4310949650 hasOpenAccess W4310949650 @default.
• W4310949650 hasPrimaryLocation W43109496501 @default.
• W4310949650 hasRelatedWork W1864361583 @default.

• next